-- Cash usage during the quarter included $2.6 million for operations and
$2.6 million for capital expenditures to expand the Company's mobile
imaging services business.
-- Receivables on March 31, 2008, were $9.8 million, compared to
$8.5 million on December 31, 2007.
-- Inventories on March 31, 2008, were $5.8 million compared to
$5.5 million on December 31, 2007.
Management Updates Guidance for Full-Year 2008
Considering current economic pressures, the early-growth phase of the Company's centers of influence, and continued volatility with its business, management anticipates consolidated revenues in a range of $75 million to $81 million, consisting of DIS revenue of $56 million to $60 million and product-related revenue of $19 million to $21 million. Management expects a consolidated net loss in a range of $2.0 million to $4.5 million, including estimated stock-based compensation expense of $1 million.
Conference Call Information
A conference call is scheduled for 11:00 a.m. EDT today to discuss the results and management's outlook. A simultaneous web cast of the call may be accessed online from the Events & Presentations link on the Investor Relations page at http://www.digirad.com; an archived replay of the webcast will be available within 15 minutes of the end of the conference call.
Digirad Corporation provides diagnostic nuclear and ultrasound imaging
systems and services to physicians' offices, hospitals and other medical
services providers for cardiac, vascular, and general imaging applications.
Digirad's Cardius XPO line of nuclear imaging cameras use patented
solid-state technology and unique multi (dual, triple) head design for
superior performance and advanced features for sharper digital images,
faster processing, compact size, lighter weight for portability, ability to
|SOURCE Digirad Corporation|
Copyright©2008 PR Newswire.
All rights reserved